Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Total Non-Current Liabilities (2020 - 2021)

Design Therapeutics' Total Non-Current Liabilities history spans 2 years, with the latest figure at $8.8 million for Q3 2021.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $8.8 million in Q3 2021 year-over-year; TTM through Sep 2021 was $8.8 million, a N/A change, with the full-year FY2020 number at $2.3 million, changed N/A from a year prior.
  • Total Non-Current Liabilities hit $8.8 million in Q3 2021 for Design Therapeutics, up from $3.4 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for DSGN hit a ceiling of $8.8 million in Q3 2021 and a floor of $2.3 million in Q4 2020.